Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
10.29
-0.43 (-4.01%)
At close: Mar 9, 2026, 4:00 PM EDT
10.45
+0.16 (1.55%)
After-hours: Mar 9, 2026, 4:13 PM EDT
Perrigo Company Revenue
In the year 2025, Perrigo Company had annual revenue of $4.25B, down -2.75%. Perrigo Company had revenue of $1.11B in the quarter ending December 31, 2025, a decrease of -2.52%.
Revenue (ttm)
$4.25B
Revenue Growth
-2.75%
P/S Ratio
0.33
Revenue / Employee
$507,590
Employees
8,100
Market Cap
1.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.25B | -120.30M | -2.75% |
| Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.27B |
| Phibro Animal Health | 1.46B |
| Evotec SE | 887.40M |
| ANI Pharmaceuticals | 883.37M |
| BioCryst Pharmaceuticals | 874.84M |
| Collegium Pharmaceutical | 780.57M |
| Pacira BioSciences | 726.41M |
| Alvotech | 573.35M |
PRGO News
- 1 day ago - 5 Small Caps With Yields Up To 11% That Punch Like Heavyweights - Forbes
- 5 days ago - Perrigo to Present at the UBS Global Consumer and Retail Conference - PRNewsWire
- 6 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga
- 11 days ago - Perrigo Company plc (PRGO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations - PRNewsWire
- 18 days ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 24 days ago - Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 - PRNewsWire
- 24 days ago - Buy 5 IDEAL S&P 600 Small/MidCap 'Safer' February DiviDogs - Seeking Alpha